Astellas Pharma (STU:YPH) Other Current Liabilities : €3,621 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Astellas Pharma Other Current Liabilities?

Astellas Pharma's other current liabilities for the quarter that ended in Mar. 2024 was €3,621 Mil.

Astellas Pharma's quarterly other current liabilities declined from Sep. 2023 (€3,594 Mil) to Dec. 2023 (€3,575 Mil) but then increased from Dec. 2023 (€3,575 Mil) to Mar. 2024 (€3,621 Mil).

Astellas Pharma's annual other current liabilities increased from Mar. 2022 (€4,015 Mil) to Mar. 2023 (€4,057 Mil) but then declined from Mar. 2023 (€4,057 Mil) to Mar. 2024 (€3,621 Mil).

Astellas Pharma Other Current Liabilities Historical Data

The historical data trend for Astellas Pharma's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astellas Pharma Other Current Liabilities Chart

Astellas Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Current Liabilities

Get a 7-Day Free Trial

Astellas Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Astellas Pharma Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Astellas Pharma Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Astellas Pharma's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Astellas Pharma (STU:YPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (STU:YPH) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

ALPMY:USA ALPMF:USA 4503:Mexico 4503:Japan YPHA:Germany

Address

2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411

Website

http://www.astellas.com

Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.

Astellas Pharma (STU:YPH) Headlines

No Headlines